SIGHT

PAR · Equity

GenSight Biologics S.A.

FR Healthcare Biotechnology

Latest week
29 May 2026
Close
0.088500
Fair value
0.306465
Expectation
Negative 41.92%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
0.09
12-Week Change
1.72%
Trend Signal
Inactive
Expectation
Negative 41.92%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-27.96
Market Dynamics
1.28

Over the latest 12 completed weeks ending 2026-05-29, SIGHT rose 1.72%, moving from 0.09 to 0.09. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -27.96 and has improved across the 12-week window. Market Dynamics is 1.28 on the latest week. Expectation is negative at 41.92%.